These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28734721)

  • 1. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.
    Ouyang H; Ma W; Liu F; Yue Z; Fang M; Quan M; Pan Z
    Pancreatology; 2017; 17(5):773-781. PubMed ID: 28734721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.
    Ouyang H; Ma W; Zhang T; Liu F; Zhao L; Fang M; Quan M; Pan Z
    Pancreatology; 2018 Dec; 18(8):983-989. PubMed ID: 30287168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases].
    Ouyang HH; Pan ZY; Ma WD; Zhao LJ; Zhang T; Liu F; Quan MM
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):425-30. PubMed ID: 26875916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.
    Ouyang H; Ma W; Jiang X; Gerdtsson AS; Liu D; Pan Z
    Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):405-412. PubMed ID: 36803208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
    Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
    Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
    Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
    DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
    Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.
    Gray PJ; Wang J; Pawlik TM; Edil BH; Schulick R; Hruban RH; Dao H; Cameron J; Wolfgang C; Herman JM
    J Surg Oncol; 2012 Jul; 106(1):66-71. PubMed ID: 22308098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
    Falchook GS; Wolff RA; Varadhachary GR
    Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis.
    Zhang Y; Dang C; Ma Q; Chen W; Nagata K
    Hepatogastroenterology; 2007; 54(73):254-9. PubMed ID: 17419272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
    Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
    Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in the operative and palliative treatment of pancreatic cancer.
    Talar-Wojnarowska R; Gasiorowska A; Strzelczyk J; Janiak A; Malecka-Panas E
    Neoplasma; 2003; 50(5):383-7. PubMed ID: 14628094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.
    Tas F; Aykan F; Alici S; Kaytan E; Aydiner A; Topuz E
    Am J Clin Oncol; 2001 Dec; 24(6):547-50. PubMed ID: 11801751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.